Ottawa, Canada

Conrad Florian Bentzinger

This inventor holds 1 USPTO granted patent. Top assignee: Ottawa Hospital Research Institute. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Conrad Florian Bentzinger. Retrieved from https://idiyas.com/inventor/conrad-florian-bentzinger-3s92eik3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Conrad Florian Bentzinger: Innovator in Stem Cell Research

Introduction

Conrad Florian Bentzinger is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of stem cell research, particularly through his innovative approaches to modulating stem cell division.

Latest Patents

Bentzinger holds a patent for "WNT7A compositions and method of using the same." This patent focuses on compositions and methods for modulating stem cell division, specifically division symmetry. The research demonstrates that Wnt7a polypeptide fragments can promote the symmetrical expansion of stem cells. The applications of this invention are vast, including the modulation of stem cell division symmetry in vitro, ex vivo, and in vivo. It also plays a crucial role in replenishing and expanding the stem cell pool, as well as promoting the formation, maintenance, repair, and regeneration of tissue.

Career Highlights

Bentzinger is affiliated with the Ottawa Hospital Research Institute, where he continues to advance his research in stem cell biology. His work has garnered attention for its potential applications in regenerative medicine and tissue repair.

Collaborations

Throughout his career, Bentzinger has collaborated with esteemed colleagues, including Michael A Rudnicki and Radoslav Zinoviev. These collaborations have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Conrad Florian Bentzinger is a pioneering inventor whose work in stem cell research has the potential to transform regenerative medicine. His innovative patent on WNT7A compositions highlights the importance of understanding stem cell division and its implications for tissue repair and regeneration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…